Search for: "Roche Laboratories Inc."
Results 81 - 100
of 139
Sorted by Relevance
|
Sort by Date
8 Dec 2010, 2:20 am
: Daiichi Sankyo Co Ltd v Comptroller General of Patents (The SPC Blog) Coversyl (Perindopril) – Australia: FCAFC: Servier denied patent amendment on appeal: Les Laboratoires Servier v Apotex (Patentology) Prandin (Repaglinide) – US: Paddock fails to dismiss Novo’s Prandin patent suit (Patent Docs) Spiriva (Tiotropium bromide monohydrate) – Israel: Patent status in question, in need of legislative fix (America-Israel Patent Law) Temodar (Temozolomide) – US: Jewish law… [read post]
22 Jun 2011, 4:09 am
A-G’s opinion published – Merck & Co Inc. v Deutsches Patent- und Markenamt (EPLAW) (The SPC Blog) US: Supreme Court to revisit patentable subject matter eligibility of medical diagnostic methods: Mayo v Prometheus (Patently-O) (Patent Baristas) (PharmaPatents) (IPBiz) (Patent Law Practice Center) US: Intellectual property problems for personalized medicine (BIOtechNow) US: Supreme Court ruling in Stanford v Roche (IPKat) (IPKat) US: Manager’s… [read post]
26 Jul 2010, 10:41 pm
Roche Laboratories is already producing and marketing a new test called the “AmpliChip CYP450”. [read post]
11 Jan 2008, 9:00 am
: (IP Spotlight)PharmaIndia: Trade mark assignment under scrutiny in a case of deceptive similarity - Doctor Morepen Limited v Yash Pharma Laboratories Limited: (Mondaq),Arrow v Merck - An early route to market for generics? [read post]
21 Oct 2009, 6:13 am
(Afro-IP) 200,000 die annually because of fake malaria medicine – Smithsonian article ‘The Fatal Consequences of Counterfeit Drugs’ (Innovationpartners) ‘Translational medicine’ (IPKat) Brazil: Brazilian Ministry of Health calls for partnerships between public laboratories and private companies (IP tango) Brazil: Rio 2016 – who will pay and how? [read post]
21 Oct 2009, 5:13 am
(Afro-IP) 200,000 die annually because of fake malaria medicine - Smithsonian article 'The Fatal Consequences of Counterfeit Drugs' (Innovationpartners) 'Translational medicine' (IPKat) Brazil: Brazilian Ministry of Health calls for partnerships between public laboratories and private companies (IP tango) Brazil: Rio 2016 - who will pay and how? [read post]
21 Oct 2009, 5:13 am
(Afro-IP) 200,000 die annually because of fake malaria medicine - Smithsonian article 'The Fatal Consequences of Counterfeit Drugs' (Innovationpartners) 'Translational medicine' (IPKat) Brazil: Brazilian Ministry of Health calls for partnerships between public laboratories and private companies (IP tango) Brazil: Rio 2016 - who will pay and how? [read post]
27 May 2010, 3:40 pm
Whitehall Laboratories, Inc., 874 F. [read post]
7 May 2009, 6:08 am
Roche Laboratories, Inc., 243 F.Supp.2d 672, 677 (W.D. [read post]
12 Feb 2009, 10:42 am
Barr Laboratories, Inc., 812 F. [read post]
6 Jul 2007, 4:29 am
Hoffman-La Roche, Inc., 618 N. [read post]
28 Apr 2011, 3:18 pm
Lederle Laboratories, 218 Cal. [read post]
20 Aug 2010, 6:27 am
Hoffmann-La Roche, Inc. v. [read post]
3 Mar 2010, 5:05 am
(IP Think Tank) US: Reverse payments in generic drug settlements (Part II - Patent Docs) (Part III - Patent Docs) (Part IV - Patent Docs) US: Inability of patent examiner and Board to correctly read prior art reference necessitates intervention by Federal Circuit: In re Chapman (Holman's Biotech IP Blog) (Patent Docs) US: Patent infringement suit between NexMed and Beta Technologies stayed following determination that plaintiff NexMed may not own one of the patents-in-suit related to method of… [read post]
3 Mar 2010, 5:05 am
(IP Think Tank) US: Reverse payments in generic drug settlements (Part II - Patent Docs) (Part III - Patent Docs) (Part IV - Patent Docs) US: Inability of patent examiner and Board to correctly read prior art reference necessitates intervention by Federal Circuit: In re Chapman (Holman's Biotech IP Blog) (Patent Docs) US: Patent infringement suit between NexMed and Beta Technologies stayed following determination that plaintiff NexMed may not own one of the patents-in-suit related to method of… [read post]
15 Jul 2009, 5:15 am
IPAB rejects Novartis’ patent application for Glivec (Intellectual Property Watch) Lescol (Fluvastatin) – Netherlands: No interim relief pending appeal against invalidity, rules District Court of The Hague: Novartis v Mylan and Actavis (PatLit) Levaquin (Levoflaxacin) – Canada: FCA holds generics raising allegations similar to those of previous generics allowed their day in court: Apotex v Janssen-Ortho (Global IP Watch) Lexapro (Escitalopram) – US: Caraco… [read post]
7 Jun 2011, 12:42 pm
Metabolite Laboratories, Inc., 548 U. [read post]
2 Oct 2008, 12:36 pm
Danek Medical, Inc., 1999 WL 1054864, *6 (M.D. [read post]
18 Feb 2010, 10:34 am
Most notably there’s Mylan Laboratories, Inc. v. [read post]
12 Jun 2013, 4:30 am
Roche Laboratories, Inc., 2013 U.S. [read post]
